Skip to search formSkip to main contentSkip to account menu

Viral Oncolysate

An extract made from cancer cells that are infected with a strain of virus that can lyse (break down) cancer cells. The extract contains both cancer… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Dendritic Cells Pulsed with Viral Oncolysate
Glioblastoma multiforme (GBM) is an aggressive malignant tumour of the central neural system (CNS). Despite an improved surgical… 
Review
1999
Review
1999
Cancer vaccines with emphasis on a viral oncolysate melanoma vaccine.
Biotherapy of malignant diseases has become the fourth treatment modality besides surgery, chemo- and radiotherapy. Whole cell… 
1993
1993
Active intralymphatic immunotherapy of uterine cervical carcinoma with viral oncolysate: a pilot study
A pilot clinical trial was conducted in patients with squamous carcinoma of the uterine cervix to evaluate the clinical and… 
1991
1991
Immunological effects of tumor vaccines: III. Influenza virus oncolysates inhibit the TPA induced activation of peripheral blood mononuclear cells.
This paper investigates the effects of tumor vaccines on T cell proliferation induced by 12-0 tetradecanoylphorbol-13-acetate… 
1989
1989
Randomized Comparison of Viral Oncolysate plus Radiation and Radiation Alone in Uterine Cervix Carcinoma
A randomized, controlled study was performed in patients with high-risk, untreated squamous cell carcinoma of the uterine cervix… 
1989
1989
Lymphokine activity in malignant effusions after intracavitary viral oncolysate.
Six patient with malignant effusions (five with ascites and one with malignant pleural effusion) due to refractory ovarian… 
1989
1989
Increased ovarian tumor cell surface reacting antibodies in patients with ovarian adenocarcinoma after viral oncolysate treatment.
Antibodies reacting with the cell surface of ovarian tumor cell lines were detected in the sera of untreated patients with… 
1989
1989
Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies.
Sera from melanoma patients undergoing immunization with three distinct immunogens were evaluated for development of IgG antibody… 
1986
1986
Malignant melanoma. Inflammatory mononuclear cell infiltrates in cerebral metastases during concurrent therapy with viral oncolysate
Five patients with advanced malignant melanomatreated with viral oncolysatehad solitary central nervous system metastases that… 
1983
1983
Early antiviral antibody response after immunization with viral oncolysate: a powerful prognostic marker for acute myelogenous leukemia remission patients.
Twenty-four acute myelogenous leukemia (AML) patients in first clinical remission received, as a part of their maintenance… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)